going from semaglutide to tirzepatide and key differences, weight loss results (2026) Switching between weight-loss medications -

Furthermore, the weight loss effect of GLP-/GIP dual agonists is achieved by combining an increase in energy expenditure with a decrease in food intake [130], and its potential in the treatment of obesity has been validated in clinical trials

However, retatrutide delivers superior weight loss results in clinical trials (up to 28.7% vs 15-17% for semaglutide), which means the cost per percentage point of weight loss can be competitive or even favorable

Cellular Dysfunction in Diabetes as Maladaptive Response to Mitochondrial Oxidative Stress

Link here: Big shift in the making

Mechanism How these two peptides work together in research models